The immunopathogenesis of narcolepsy type 1

RS Liblau, D Latorre, BR Kornum… - Nature Reviews …, 2024 - nature.com
Abstract Narcolepsy type 1 (NT1) is a chronic sleep disorder resulting from the loss of a
small population of hypothalamic neurons that produce wake-promoting hypocretin (HCRT; …

Psoriasis: which therapy for which patient: psoriasis comorbidities and preferred systemic agents

SB Kaushik, MG Lebwohl - Journal of the American Academy of …, 2019 - Elsevier
Psoriasis is a systemic inflammatory disease associated with increased risk of comorbidities,
such as psoriatic arthritis, Crohn's disease, malignancy, obesity, and cardiovascular …

CNS demyelination with TNF-α blockers

E Kemanetzoglou, E Andreadou - Current neurology and neuroscience …, 2017 - Springer
Tumor necrosis factor–α (TNF-α) blockers are a popular therapeutic choice in a number of
inflammatory diseases. Thus far, five TNF-α blockers have been approved for clinical use …

Multiple sclerosis: geoepidemiology, genetics and the environment

R Milo, E Kahana - Autoimmunity reviews, 2010 - Elsevier
Multiple sclerosis (MS) is a chronic immune-mediated demyelinating disease of the central
nervous system characterized by relapses and remissions. The risk of acquiring this …

Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases

GS Cooper, MLK Bynum, EC Somers - Journal of autoimmunity, 2009 - Elsevier
Previous studies have estimated a prevalence of a broad grouping of autoimmune diseases
of 3.2%, based on literature review of studies published between 1965 and 1995, and 5.3 …

Psoriasis as an immune-mediated and inflammatory systemic disease: from pathophysiology to novel therapeutic approaches

A Campanati, A Marani, E Martina, F Diotallevi, G Radi… - Biomedicines, 2021 - mdpi.com
Psoriasis is an immune-mediated inflammatory disease, with a chronic relapsing-remitting
course, which affects 2–3% of the worldwide population. The progressive acquisitions of the …

Incidence of acquired demyelination of the CNS in Canadian children

B Banwell, J Kennedy, D Sadovnick, DL Arnold… - Neurology, 2009 - AAN Enterprises
Background: The incidence of acquired demyelination of the CNS (acquired demyelinating
syndromes [ADS]) in children is unknown. It is important that physicians recognize the …

How do autoimmune diseases cluster in families? A systematic review and meta-analysis

J Cárdenas-Roldán, A Rojas-Villarraga, JM Anaya - BMC medicine, 2013 - Springer
Background A primary characteristic of complex genetic diseases is that affected individuals
tend to cluster in families (that is, familial aggregation). Aggregation of the same …

Associated autoimmune diseases in children and adolescents with type 1 diabetes mellitus (T1DM)

K Kakleas, A Soldatou, F Karachaliou… - Autoimmunity reviews, 2015 - Elsevier
Abstract Type 1 diabetes (T1DM) is an autoimmune disease with aberrant immune
responses to specific β-cell autoantigens, resulting in insulin deficiency. Children and …

Modest familial risks for multiple sclerosis: a registry-based study of the population of Sweden

H Westerlind, R Ramanujam, D Uvehag… - Brain, 2014 - academic.oup.com
Data on familial recurrence rates of complex diseases such as multiple sclerosis give
important hints to aetiological factors such as the importance of genes and environment. By …